TFS Explore focuses on early stage clinical trials in Phase 0, I and IIa. This includes integrated protocols and early proof-of-concept studies in special patient populations, as well as Positron Emission Tomography (PET) imaging studies.
Many of our early Clinical trials are conducted at the Karolinska University Hospital in Stockholm, Sweden, in a clinical unit approved by both the US FDA and Swedish Medical Product Agency (MPA). The research facility provides 16-20 beds in a modern facility with state-of-the art equipment to support eg. FIM studies. Depending on the customer needs and type of study, we use other sites as well to provide the most efficient solution.
TFS Explore actively assists and supports the initiation and preparation of the study outline, protocol development, project management, data management, biostatistics, medical writing and CRF development. We can also provide scientific input, drawing on the extensive network of specialists associated with the Karolinska University Hospital.
Contact Jan Hellqvist, Regional Managing Director Northern Europe, on +46 (0)46 280 19 02, to learn how TFS Explore can help your company with early stage clinical trials.
Swedish Medical Product Agency (MPA)
Inspection Report 2010
Swedish Medical Product Agency (MPA)
Inspection Report 2008
Position paper on Phase I trials
The Phase I Unit
Karolinska Scientific Advisory Board
To receive a copy of our Phase I brochure, click here.
